![OptiNose, Inc. logo](/logos/OPTN.webp)
OptiNose, Inc.
NASDAQ:OPTN
Overview | Financials
Company Name | OptiNose, Inc. |
Symbol | OPTN |
Currency | USD |
Price | 0.952 |
Market Cap | 143,494,471 |
Dividend Yield | 0% |
52-week-range | 0.8 - 2.1 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Ramy A. Mahmoud M.D., M.P.H. |
Website | https://www.optinose.com |
An error occurred while fetching data.
About OptiNose, Inc.
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD